Flossbach Von Storch Ag Becton Dickinson & CO Transaction History

Flossbach Von Storch Ag

$23.7 Billion
Q2 2024

A detailed history of Flossbach Von Storch Ag transactions in Becton Dickinson & CO stock. As of the latest transaction made, Flossbach Von Storch Ag holds 287,410 shares of BDX stock, worth $69.4 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

287,410

Previous 230,441 24.72%

Holding current value

$69.4 Million

Previous $57 Million 17.8%

% of portfolio

0.28%

Previous 0.25%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$225.07 - $246.17 $12.8 Million - $14 Million	56,969 Added 24.72%	287,410 $67.2 Million
Q1 2024 May 06, 2024	SELL	$233.45 - $247.73 $10 Million - $10.6 Million	-42,894 Reduced 15.69%	230,441 $57 Million
Q4 2023 Jan 31, 2024	BUY	$232.24 - $267.23 $4.87 Million - $5.6 Million	20,962 Added 8.31%	273,335 $66.6 Million
Q3 2023 Oct 27, 2023	BUY	$254.9 - $283.59 $4.4 Million - $4.9 Million	17,278 Added 7.35%	252,373 $65.2 Million
Q2 2023 Aug 02, 2023	BUY	$238.39 - $265.32 $2.46 Million - $2.74 Million	10,320 Added 4.59%	235,095 $62.1 Million
Q1 2023 May 03, 2023	BUY	$229.71 - $259.35 $2.32 Million - $2.62 Million	10,115 Added 4.71%	224,775 $55.6 Million
Q4 2022 Feb 06, 2023	BUY	$218.29 - $256.91 $3.52 Million - $4.15 Million	16,140 Added 8.13%	214,660 $54.6 Million
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $1.23 Million - $6.35 Million	-24,032 Reduced 10.8%	198,520 $44.2 Million
Q2 2022 Aug 10, 2022	SELL	$234.74 - $275.42 $11.6 Million - $13.6 Million	-49,538 Reduced 18.21%	222,552 $54.9 Million
Q1 2022 May 11, 2022	SELL	$243.64 - $270.48 $79.4 Million - $88.2 Million	-325,987 Reduced 54.51%	272,090 $72.4 Million
Q4 2021 Feb 04, 2022	SELL	$230.08 - $250.94 $422 Million - $460 Million	-1,835,068 Reduced 75.42%	598,077 $150 Million
Q3 2021 Nov 04, 2021	SELL	$232.72 - $256.47 $144 Million - $158 Million	-616,967 Reduced 20.23%	2,433,145 $598 Million
Q2 2021 Aug 02, 2021	SELL	$232.65 - $254.58 $10.3 Million - $11.2 Million	-44,072 Reduced 1.42%	3,050,112 $742 Million
Q1 2021 May 04, 2021	SELL	$232.09 - $256.88 $20.3 Million - $22.5 Million	-87,435 Reduced 2.75%	3,094,184 $752 Million
Q4 2020 Feb 09, 2021	BUY	$221.92 - $245.94 $127 Million - $141 Million	572,178 Added 21.93%	3,181,619 $796 Million
Q3 2020 Nov 05, 2020	BUY	$215.77 - $276.76 $20.6 Million - $26.4 Million	95,446 Added 3.8%	2,609,441 $607 Million
Q2 2020 Aug 10, 2020	BUY	$219.9 - $263.41 $141 Million - $168 Million	638,932 Added 34.08%	2,513,995 $602 Million
Q1 2020 May 11, 2020	BUY	$195.69 - $279.01 $282 Million - $403 Million	1,443,558 Added 334.54%	1,875,063 $431 Million
Q4 2019 Feb 11, 2020	BUY	$236.45 - $266.82 $6.81 Million - $7.69 Million	28,820 Added 7.16%	431,505 $117 Million
Q3 2019 Nov 08, 2019	BUY	$230.58 - $256.08 $13.9 Million - $15.4 Million	60,255 Added 17.6%	402,685 $102 Million
Q2 2019 Aug 06, 2019	BUY	$217.4 - $246.08 $52.4 Million - $59.3 Million	240,930 Added 237.37%	342,430 $86.3 Million
Q1 2019 May 02, 2019	BUY	$206.05 - $248.17 $4.33 Million - $5.21 Million	21,000 Added 26.09%	101,500 $25.3 Million
Q4 2018 Feb 05, 2019	BUY	$204.73 - $257.93 $15 Million - $19 Million	73,500 Added 1050.0%	80,500 $18.1 Million
Q3 2018 Nov 05, 2018	SELL	$233.07 - $256.0 $605,982 - $665,600	-2,600 Reduced 27.08%	7,000 $1.83 Million
Q2 2018 Aug 08, 2018	SELL	$208.1 - $233.85 $1.6 Million - $1.8 Million	-7,700 Reduced 44.51%	9,600 $2.3 Million
Q1 2018 May 04, 2018	BUY	$205.46 - $240.27 $3.55 Million - $4.16 Million	17,300 New	17,300 $3.75 Million

Others Institutions Holding BDX

# of Institutions

1,734

Shares Held

252M

Call Options Held

586K

Put Options Held

649K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $68.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flossbach Von Storch Ag, based on Form 13F filings with the SEC.

News

Stay updated on Flossbach Von Storch Ag with notifications on news.

Account

Flossbach Von Storch Ag Becton Dickinson & CO Transaction History